--- title: "Cachet Pharmaceutical Co.,Ltd. (002462.SZ)" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/002462.SZ.md" symbol: "002462.SZ" name: "Cachet Pharmaceutical Co.,Ltd." industry: "Health Care Distributors" datetime: "2026-03-03T11:35:30.951Z" locales: - [en](https://longbridge.com/en/quote/002462.SZ.md) - [zh-CN](https://longbridge.com/zh-CN/quote/002462.SZ.md) - [zh-HK](https://longbridge.com/zh-HK/quote/002462.SZ.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/002462.SZ.md) | [繁體中文](https://longbridge.com/zh-HK/quote/002462.SZ.md) # Cachet Pharmaceutical Co.,Ltd. (002462.SZ) ## Company Overview Cachet Pharmaceutical Co., Ltd. engages in the wholesale, retail, and logistics of pharmaceutical products in China. The company also offers medical devices. It sells its products through online and offline channels. | Item | Detail | |------|--------| | Industry | Health Care Distributors | | Exchange | CN Market | | Website | [www.cachet.com.cn](https://www.cachet.com.cn) | ## Key Drivers > *AI-analyzed key factors driving this stock's performance* ## Longbridge Financial Score™: C > *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge* > Updated: 2026-03-03T04:30:10.000Z **Overall: C (0.52)** **Industry**: Health Care Distributors | Metric | Value | |--------|-------| | Industry Ranking | 17 / 25 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock. **Multi Score**: C #### Style Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -25.14% | | | Net Profit YoY | -70.91% | | | P/B Ratio | 1.01 | | | Dividend Ratio | 1.11% | | #### Size Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 4479323847.34 | | | Revenue | 20059670374.76 | | #### Multi Score Score: C | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 1.61% | C | | Profit Margin | 0.36% | C | | Gross Margin | 6.15% | E | | Revenue YoY | -25.14% | E | | Net Profit YoY | -70.91% | E | | Total Assets YoY | -12.63% | E | | Net Assets YoY | -1.75% | D | | Cash Flow Margin | 28140.77% | A | | OCF YoY | -25.14% | E | | Turnover | 1.47 | A | | Gearing Ratio | 51.94% | C | ```chart-data:radar { "title": "Longbridge Financial Score - Cachet Pharmaceutical Co.,Ltd.", "chart_type": "radar", "dimensions": [ { "name": "Style Score", "grade": "", "indicators": [ { "name": "Revenue YoY", "value": "-25.14%", "rating": "" }, { "name": "Net Profit YoY", "value": "-70.91%", "rating": "" }, { "name": "P/B Ratio", "value": "1.01", "rating": "" }, { "name": "Dividend Ratio", "value": "1.11%", "rating": "" } ] }, { "name": "Size Score", "grade": "", "indicators": [ { "name": "Market Cap", "value": "4479323847.34", "rating": "" }, { "name": "Revenue", "value": "20059670374.76", "rating": "" } ] }, { "name": "Multi Score", "grade": "C", "indicators": [ { "name": "ROE", "value": "1.61%", "rating": "C" }, { "name": "Profit Margin", "value": "0.36%", "rating": "C" }, { "name": "Gross Margin", "value": "6.15%", "rating": "E" }, { "name": "Revenue YoY", "value": "-25.14%", "rating": "E" }, { "name": "Net Profit YoY", "value": "-70.91%", "rating": "E" }, { "name": "Total Assets YoY", "value": "-12.63%", "rating": "E" }, { "name": "Net Assets YoY", "value": "-1.75%", "rating": "D" }, { "name": "Cash Flow Margin", "value": "28140.77%", "rating": "A" }, { "name": "OCF YoY", "value": "-25.14%", "rating": "E" }, { "name": "Turnover", "value": "1.47", "rating": "A" }, { "name": "Gearing Ratio", "value": "51.94%", "rating": "C" } ] } ] } ``` ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | 62.84 | 18/25 | 63.33 | 39.55 | 29.13 | | PB | 1.01 | 7/25 | 1.02 | 0.93 | 0.87 | | PS (TTM) | 0.22 | 6/25 | 0.23 | 0.19 | 0.18 | | Dividend Yield | 1.11% | 14/25 | 1.98% | 1.22% | 1.10% | ## Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | | --- | --- | --- | --- | --- | --- | --- | --- | | 01 | HUADONG MEDICINE (000963.SZ) | B | C | A | B | B | B | | 02 | Jointown (600998.SH) | C | B | A | D | B | B | | 03 | SINOPHARM(CNCM LTD) (600511.SH) | C | C | A | C | B | B | | 04 | Shanghai Pharma (601607.SH) | C | C | A | D | B | C | | 05 | GYBYS (600332.SH) | C | C | A | C | B | C | ## References - [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/002462.SZ/overview.md) - [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/002462.SZ/norm.md) - [Related News](https://longbridge.com/en/quote/002462.SZ/news.md) - [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/002462.SZ/filings.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**